45243-3

Reason for discontinuation of anti-infective phrophylaxis medication

Active

LOINC Names Get Info

Fully-Specified Name: Reason for discontinuation of anti-infective phrophylaxis medication:Type:Pt:^Patient:Nom:Reported
Long Common Name: Reason for discontinuation of anti-infective phrophylaxis medication
Short Name: Reason for d/c of anti-infect proph Rx

Part Model Get Info

Component
Reason for discontinuation of anti-infective phrophylaxis medication
LP73232-8
- Analyte
  Reason for discontinuation of anti-infective phrophylaxis medication
  LP73232-8
  - Component Numerator
    Reason for discontinuation of anti-infective phrophylaxis medication
    LP73232-8
    - Component Numerator Core
      Reason for discontinuation of anti-infective phrophylaxis medication
      LP73232-8
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  NULL
- Adjustment
  NULL
- Count
  NULL
Property
Type
LP6886-8
Time
Pt
LP6960-1
- Time Core
  Pt
  LP6960-1
- Time Modifier
  NULL
System
^Patient
LP310005-6
- System Core
  NULL
- Super System
  Patient
  LP6985-8
Scale
Nom
LP7750-5
Method
Reported
LP6486-7

Normative Answer List: LL354-2

Answer	Code	Answer ID
Toxicity/Side Effects	1	LA6529-7
Pregnancy	2	LA6530-5
Risk of Pregnancy	3	LA6531-3
Newly Diagnosed TB	4	LA6532-1
New Drug Available	5	LA6533-9
Drug Out of Stock	6	LA6534-7
Other Reason	7	LA6535-4

Basic Attributes

Class: ART
Type: Clinical
First Released: Version 2.17
Last Updated: Version 2.67 (MIN)

Member of these Panels

LOINC	Long Common Name
47245-6	HIV treatment form Document

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=45243-3

Copyright

Organization: World Health Organization (WHO)
Terms of Use: Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
URL: https://www.who.int/about/policies/publishing/copyright

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.